Walnut Consumption, Endothelial Function, and Biomarkers



Status:Completed
Conditions:Peripheral Vascular Disease, Cardiology, Cardiology, Diabetes, Diabetes
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology
Healthy:No
Age Range:30 - Any
Updated:4/21/2016
Start Date:June 2013
End Date:September 2015

Use our guide to learn which trials are right for you!

Walnut Consumption, Endothelial Function, and Plasma Adipokines in Subjects With Diabetes or Coronary Disease: a Pilot Trial

This study will examine whether a twelve-week intervention with one ounce (28 g) per day of
walnuts improves endothelial function measured non-invasively using finger probe
(EndoPat-2000) in people with coronary heart disease or type 2 diabetes.


Inclusion Criteria:

- Age 30+ years

- Prevalent coronary artery disease

- Prevalent type 2 diabetes

Exclusion Criteria:

- Current eating disorder

- Pregnant or lactating women

- Allergy to walnuts or other nuts

- Inability to provide informed consent or blood samples

- History or prevalent diagnosis of cancer, asthma, kidney insufficiency, stroke,
seizures, allergic disorders, or congestive heart failure

- Diagnosis of coronary heart disease or diabetes < 1 year prior to enrollment

- Intention to move out of greater Boston area within one year

- Current use of walnuts for more than 2 ounces per day

- Bleeding disorder

- Treatment with blood thinning drugs (i.e. warfarin, clopidogrel)

- Major surgical operation 3 months before or after screening

- Organ transplantation

- Current participation in another trial or plan to do so during the study

- Use of vasodilators such as nitroglycerin

- Inability to give informed consent

- Inability to travel to the study center at Brigham and Women's Hospital
We found this trial at
1
site
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials